Immuneering Corp (IMRX)
1.615
+0.06
(+3.53%)
USD |
NASDAQ |
May 03, 13:23
Immuneering Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -2.91M% |
| September 30, 2022 | -33.47K% |
| June 30, 2022 | -12.21K% |
| March 31, 2022 | -7.02K% |
| December 31, 2021 | -5.69K% |
| September 30, 2021 | -1.77K% |
| Date | Value |
|---|---|
| June 30, 2021 | -1.21K% |
| March 31, 2021 | -832.6% |
| December 31, 2020 | -877.5% |
| September 30, 2020 | -644.5% |
| June 30, 2020 | -749.6% |
| March 31, 2020 | -662.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.91M%
Minimum
Dec 2022
-644.5%
Maximum
Sep 2020
-248.0K%
Average
-1.49K%
Median
Profit Margin (Quarterly) Benchmarks
| Geron Corp | -226.0K% |
| SELLAS Life Sciences Group Inc | -- |
| Elicio Therapeutics Inc | -- |
| Vistagen Therapeutics Inc | -1.54K% |
| ADMA Biologics Inc | -23.88% |